Loading…
Based on limited metadata, Sovereign Laboratories, LLC received an FDA Warning Letter on June 15, 2020 regarding drug products. Without access to the full letter text or detailed subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug regulatory authority, though the specific issuing office is not identified in the metadata provided. To understand the particular compliance issues cited, review of the complete Warning Letter would be necessary.